CD274 and non-small cell lung carcinoma: Assuming that mRNA vaccines targeting SARS-CoV-2 would similarly increase the PD-L1 TPS, more recent studies found that patients with advanced NSCLC were more likely to have elevated expression of this checkpoint molecule if they were vaccinated less than 100 days before diagnostic biopsy [58].